Advanced Psilocybin Delivery System Emerging Sexual Health and Wellness Company Announces Development of Muco-Adhesive Strip Technology for the Delivery of Psilocybin
VANCOUVER, BC / ACCESSWIRE / October 20, 2021 / LOVE Pharma Co. (CSE:LUV)(FSE:G1Q0), the Company has announced that it is developing a muco-adhesive sublingual strip. The Company is partnering with the strip's creator, a US based pharmaceutical company, to develop it for use as a psilocybin delivery system.
As psilocybin (the psychoactive chemical in so-called "magic mushrooms")-having gained increased legitimacy in the mental healthcare field, following a 2018 "breakthrough" designation by the FDA, thereby allowing for the fast-tracking of drug trials-has become the lynchpin of an emerging health and wellness market; ensuring the safety of users through reliable systems of accurate dosing remains of paramount importance. Difficult to achieve with botanicals, pioneering companies including LOVE Pharma are developing new extracted products designed to deliver the most consistently accurate dosing possible. LOVE Pharma has acquired the rights for a muco-adhesive sublingual strip that it is currently developing for use with psilocybin.
https://www.accesswire.com/668834/LOVE-Pharma-Announces-Advanced-Psilocybin-Delivery-System